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Background: Excessive tryptophan metabolism to kynurenine by the rate-limiting enzyme endothelial indoleamine
2,3-dioxygenase 1 (IDO) controls arterial vessel relaxation and causes hypotension in murine endotoxemia. However,
its relevance in human endotoxemia has not been investigated so far. We thus aimed to study changes in blood
pressure in parallel with tryptophan and kynurenine levels during experimental endotoxemia in humans.
Findings: Six healthy male volunteers were given E. coli lipopolysaccharide (LPS; 4 ng/kg) as a 1-min intravenous
infusion. They had levels of soluble E-Selectin and soluble vascular cell adhesion molecule-1 as well as IDO activity
assessed as the kynurenine-to-tryptophan plasma ratio by liquid chromatography-tandem mass spectrometry at
various time points during a 24 h time course. During endotoxemia, IDO activity significantly increased, reaching
peak levels at 8 h after LPS infusion (44.0 ± 15.2 vs. 29.4 ± 6.8 at baseline, P<0.0001). IDO activity correlated
inversely with the development of hypotension as shown by random effects linear regression models. Finally, IDO
activity exhibited a kinetic profile similar to that of soluble endothelial-specific adhesion molecules.
Conclusions: LPS is a triggering factor for the induction of IDO in men. Our findings strongly support the concept
that the induction of IDO in the vascular endothelium contributes to hypotension in human sepsis.Introduction
Loss of vascular tone is an important factor in the devel-
opment of severe sepsis, septic shock and multiple organ
failure. Recent work by Wang and colleagues provided
experimental evidence that kynurenine, a metabolite of
the amino acid L-tryptophan, is a mediator of vasodila-
tion and subsequent hypotension during murine endo-
toxemia [1]. In different mouse models of sepsis and
additional in vitro experiments, they found that kynure-
nine acts as a novel endothelium-derived relaxing factor
on resistance vessels by stimulating the activity of
soluble guanylyl cyclase and adenylyl cyclase in smooth
muscle cells. In addition the authors could show that
injecting mice with bacterial lipopolysaccharide (LPS)
specifically induces the rate-limiting enzyme for kynure-
nine production, namely indoleamine 2,3-dioxygenase 1
(IDO), in vascular endothelial cells [1]. Consistent with* Correspondence: philipp.kuempers@ukmuenster.de
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reproduction in any medium, provided the orthese findings, pharmacological blockade or genetic dele-
tion of IDO increases survival in murine endotoxemia [2].
However, animal studies are potentially confounded by
major inter-species differences in the sensitivity and
immune response to various types of inflammatory stimuli
[3]. The aim of this study was thus to correlate temporal
changes in IDO activity (plasma kynurenine/L-tryptophan
ratio) with the onset of hypotension in humans. Therefore,
we re-measured plasma kynurenine and L-tryptophan,
and calculated the IDO activity in serial samples from a
well-defined human endotoxemia model [4,5].Materials and methods
Endotoxemia model
Six healthy male subjects, aged 32 ± 4 years, were admit-
ted to the research unit of our intensive care department.
The local medical ethics committee (Medisch Ethische
Toetsingsingscommissie, METc, of the University Medical
Center Groningen, NL) approved the study and written
informed consent was obtained from all subjects before
enrolment. Subjects were admitted 15 h prior to endo-
toxin infusion. A radial artery catheter was placed forl Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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During the study, systolic blood pressure (SBP), diastolic
blood pressure (DBP), mean arterial pressure (MAP) and
pulse rate were measured continuously. At time point zero
(0 h) the volunteers received a 1-min infusion of endo-
toxin (Escherichia coli LPS, batch EC-6, US Pharmacopeia,
Twinbrook Parkway, Rockville, MD, USA) at a dose of
4 ng/kg body weight (10,000 endotoxin units/μg) via an
indwelling venous catheter. Blood samples for marker ana-
lysis were obtained pre-dose and at several time points up
to 24 h after endotoxin infusion. All samples were imme-
diately placed on ice, centrifuged (1,500G, 15 min, 4°C)
and stored at -70°C until analysis. Data from this study
have been reported extensively elsewhere [4,5].
Quantification of tryptophan, kynurenine, and soluble
adhesion molecules
Levels of tryptophan and kynurenine were determined
using a liquid chromatography-tandem mass spectro-
metry (LC-MS/MS) method utilizing deuterated internal
standards for both analytes. The method was adapted
from de Jong et al. [6]. In short, plasma samples were
prepared for analysis by protein precipitation with aceto-
nitril. After centrifugation, the clear supernatant was
stripped from the acetonitrile portion by vacuum centri-
fugation and the aqueous residue was injected into the
LC-MS/MS system. Chromatographic separation was
achieved on a porous graphitic carbon column with the
dimensions 50 × 2 mm by a short step gradient (0.1%Table 1 Time course after LPS infusion in healthy volunteers
Time course after LPS infusi
Variables Pre-Dose 1 h 1.5 h 2 h 2.5
HEMODYNAMICS
SBP (mmHg) 140 ± 14 139 ± 11 152 ± 11 158 ± 18* 151
DBP (mmHg) 74 ± 10 74 ± 7 80 ± 7 77 ± 12 65 ±
MAP (mmHg) 96 ± 11 96 ± 9 104 ±7 104 ± 13 94 ±
Heart rate (bpm) 61 ± 16 59 ± 11 78 ± 19 78 ± 18 92 ±
HR/MAP index 0.64 ± 0.11 0.62 ± 0.11 0.75 ± 0.17 0.76 ± 0.22 1.01
0.22
TRYPTOPHAN
METABOLISM
IDOc activity 29.4 ± 6.8 30.5 ± 7.4 30.3 ± 6.2 30.2 ± 6.8 30.2
6.4
ADHESION
MOLECULES
sEsel (ng/ml) 34 ± 16 38 ± 18 35 ± 16 40 ± 18 44 ±
sVCAM-1 (ng/ml) 307 ± 108 330 ± 120 315 ± 103 326 ± 100 319
109
A repeated-measures ANOVA with Dunnett’s test for multiple comparison (two side
variables during the time course after endotoxin infusion (n=6). Two-sided p-values
DBP – diastolic blood pressure; MAP mean arterial blood pressure; HR/MAP index -
soluble vascular cell adhesion molecule-1; IDO - Indoleamine 2,3-dioxygenase 1; *sttrifluoroacetic acid in water: acetonitrile 90:10, in 1 min
to 50:50, 0.25 ml/min flow rate). Calibration ranges were
10-200 μmol/l for tryptophan and 0.5-10 μmol/l for
kynurenine, respectively. Relative standard deviations
were less than 5% for both substances at all quality control
levels. IDO activity was calculated (IDOc) as the kynure-
nine to tryptophan ratio x 1000. Soluble E-Selectin (sEsel)
and soluble vascular cell adhesion molecule-1 (sVCAM-1)
levels were measured using FluorokineW MultiAnalyte
Profiling kits and a LuminexW Bioanalyzer (R&D Systems,
Oxon, U.K.) according to the manufacturers’ instructions
and have been reported elsewhere [7].
Statistical analysis
Continuous variables are expressed as means ± one
standard deviation (SD). A repeated-measures one-way
analysis of variance with Dunnett’s test for multiple com-
parisons (two-sided) was used to demonstrate statistical
changes in hemodynamic and laboratory variables after
endotoxin infusion. Two-sided p-values < 0.05 were con-
sidered statistically significant. The association between
IDOc activity and hemodynamic parameters measured re-
peatedly at various time points in the same person was
examined in random effects linear regression models
treating hemodynamic parameters as dependent variables
and using maximum likelihood estimators. The asso-
ciation between adhesion molecules and IDOc activity was
assessed in a similar manner, treating IDOc activity as
dependent variable. To fulfil the assumptions needed foron
h 3.5 h 4.5 h 6.5 h 8 h 24 h P-value
± 18 142 ± 22 121 ±
18*
107 ±
11*
104 ±
11*
131 ± 11 <0.0001
12 61 ± 14* 54 ± 11* 55 ± 8* 55 ± 7* 66 ± 7 <0.0001
14 88 ± 16 77 ± 13* 72 ± 8* 71 ± 7* 88 ± 7 <0.0001
12 98 ± 8 101 ± 8 97 ± 11 96 ± 13 81 ± 16 <0.0001
±
*
1.15 ±
0.26*
1.36 ±
0.32*
1.36 ±
0.27*
1.4 ±
0.22*
0.92 ±
0.16*
<0.0001
± 28.2 ±
3.6
28.6 ±
7.2
38.1 ±
10.9*
44.0 ±
15.2*
36.3 ±
12.3*
<0.0001
24 82 ± 48 184 ±
90*
289 ±
133*
243 ±
95*
208 ±
81*
<0.0001
± 326 ±
122
403 ±
86*
542 ±
92*
550 ±
91*
553 ±
130*
<0.0001
d) was used to demonstrate statistical changes in clinical and laboratory
<0.05 were considered statistically significant. SBP – systolic blood pressure;
heart rate/mean arterial pressure index; sEsel – soluble E-selectin; sVCAM-1 –
atistically significant vs. Pre-Dose.
Figure 1 Time course of blood pressure, endothelial
inflammation, and indoleamine 2,3-dioxygenase 1 activity
during human endotoxemia. Activity of Indoleamine 2,3-
dioxygenase 1 (IDO), calculated as the kynurenine to tryptophan
ratio x 1000, compared with A) systolic blood pressure (SBP) and
diastolic blood pressure (DBP) and B) plasma levels of endothelial
soluble adhesion molecules E-selectin (sEsel) and vascular-cellular
adhesion molecule-1 (sVCAM-1) after endotoxin infusion in six
healthy volunteers.
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performed. Results are shown as beta-coefficients that
correspond to a one SD higher value of each of the inde-
pendent variables in each regression.
Results
LPS infusion elicited a significant laboratory and clinical
inflammatory response with chills, headache, muscle pain,
increased heart rate, and overt hypotension (Table 1). In
brief, SBP was 140 ± 14 mmHg at 0 h, minimal at 8 h
(104 ± 11 mmHg) and remained below baseline until 20 h
(Figure 1A). Details on additional hemodynamics are
given in Table 1. Two volunteers received 1000 mL of
0.9% saline i.v. due to a SBP below 70 mmHg. No vaso-
pressors were needed. At 24 h, all volunteers were asymp-
tomatic and all clinical parameters within the normal
range. Consistent with maximal hypotension, IDOc
activity significantly increased at 6.5 h and peaked at 8 h
(44.0 ± 15.2 vs. 29.4 ± 6.8 at baseline, P<0.0001,
Figure 1A). In random effects linear regression models,
IDOc activity was significantly associated with the degree
of hypotension (SBP: β = -9.948 (95% confidence interval
[CI] -16.361 to -3.535), p = 0.002; DBP: β = -3.907 (95%
CI -7.448 to -0.336), p = 0.031; MAP: β = -5.725 (95% CI
-9.922 to -1.529), p = 0.007).
Wang et al. [1] reported that IDO is specifically
expressed induced in the inflamed endothelium of septic
mice. Consistent with this notion, the increase in
sVCAM-1 (P<0.0001) and soluble E-Selectin (P<0.0001),
surrogates for endothelial inflammation, exhibited a
kinetic profile similar to that of IDOc in our human
endotoxemia model (Figure 1B). IDOc activity was
tightly associated with plasma levels of sVCAM-1
(β = 5.07 (95% CI 3.25 to 6.9); p < 0.0001) and sEsel
(β = 3.62 (95% CI 1.86 to 5.38); p < 0.0001) using
random effects linear regression.
Discussion
Here we show that, as in mice [1], LPS is a triggering
factor for the induction of IDO in humans. Consistent
with experimental findings by Wang and colleagues [1],
we could show that IDOc was associated with the extent
of endothelial inflammation and correlated inversely
with the development of hypotension. In support of our
findings, Changsirivathanathamrong et al. [8] convin-
cingly demonstrated in a clinical study, that IDOc acti-
vity correlates with vasopressor requirement in patients
with septic shock. Darcy et al. could show that IDOc
activity correlates with severity measures such as the
Sequential Organ Failure Assessment (SOFA) score [9].
Zeden and colleagues demonstrated that septic shock
coincidence with an exacerbation of kynurenine pathway
activity [10]. Additionally, investigations revealed IDO
activity to be an independent predictor of disease severityand case fatality in bacteremic patients [11]. Thus, our
data add a further translation of previous experimental
and clinical work, strengthening the concept that IDO is a
novel mediator of arterial vessel relaxation and temporally
coupled to the onset and severity of hypotension in
human sepsis.
A possible limitation of the current study is that we can-
not rule out loss of tryptophan and kynurenine due to
deep-freeze storage for several years. However, values at
baseline (i.e. before LPS infusion) match those of healthy
controls from the literature. Furthermore, as the study is a
re-analysis of blood samples from a placebo-controlled
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hibition in endotoxemia [4,5], the intake of tryptophan
was not standardized. Infusion of LPS in healthy volun-
teers may be regarded an insufficient model for severe
sepsis/ septic shock. This model enabled us nonetheless to
study the time course of IDO induction in humans for the
first time. Another possible limitation might be the small
number of participants. However, due to statistical analysis
using advanced random effects linear regression models,
in which the respective parameters are “correlated” with
each other throughout the whole time course, a small
number of study participants should not be crucial. Fi-
nally, we cannot exclude an impact of fluid administration
(1000 ml saline 0.9% in two patients) on tryptophan and
kynurenine levels. While the impact of fluid administra-
tion on the concentration of both substances cannot be
excluded, calculation of IDO activity should not be
affected, as a potential dilution would decrease both
amino acids to the same extent.
Conclusions
In conclusion, our findings support the concept that
IDO, the rate-limiting enzyme for tryptophan cata-
bolism, is a novel and previously unrecognized mediator
of hypotension that might be particularly significant in
human sepsis [12].
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